Bio-Rad Laboratories Inc Cl B (BIO.B)

$295.05 -17.70 (-5.66%)
Market Cap 8.44B
Revenue (ttm) 2.57B
Net Income (ttm) -1.84B
EPS (ttm) N/A
PE Ratio 30.14
Forward PE N/A
Profit Margin -71.86%
Debt to Equity Ratio 0.18
Volume 1,900
Avg Vol 578
Day's Range N/A - N/A
Shares Out 26.98M
Stochastic %K 30%
Beta 1.01
Analysts Strong Buy
Price Target N/A
MorenitaScorp
MorenitaScorp Sep. 11 at 1:28 AM
$BIO.B 🔬
0 · Reply
Bullish_Scanner
Bullish_Scanner Aug. 28 at 12:28 PM
Premarket Gappers $CWD $WAI $RAYA $TELO $BIO.B
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 31 at 7:05 PM
$BIO.B Excellent article that nails exactly where BIO-B stands right now. So if you want to update your BIO-B knowledge or get acquainted with BIO-B, this is a must read. https://beyondspx.com/article/bio-rad-laboratories-navigating-headwinds-with-strategic-investments-and-technological-edge-bio-b
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 9 at 11:14 AM
$BIO.B Excellent article that nails exactly where BIO-B stands right now. So if you want to update your BIO-B knowledge or get acquainted with BIO-B, this is a must read. https://beyondspx.com/article/bio-rad-laboratories-navigating-headwinds-with-strategic-investments-and-technological-edge-bio-b
0 · Reply
Robert1999
Robert1999 Aug. 2 at 4:24 PM
$BIO.B amazing today, Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Guidance Lowered🤩🤩. Hoping for positive news from $CBIO soon🥹🥹.
0 · Reply
Financhill
Financhill Dec. 6 at 8:00 AM
$BIO.B is rated a Sell since April 12, 2023 and is 42% below its median level.
0 · Reply
EarningsInsider
EarningsInsider Aug. 30 at 10:23 PM
Bio-Rad Laboratories, Inc. Files SEC Form 144 $BIO.B https://www.marketbeat.com/stocks/NYSE/BIO.B/sec-filings/
0 · Reply
EarningsInsider
EarningsInsider Aug. 4 at 8:54 PM
Bio-Rad Laboratories, Inc. Files SEC Form 10-Q $BIO.B https://www.marketbeat.com/stocks/NYSE/BIO.B/sec-filings/
0 · Reply
EarningsInsider
EarningsInsider Jul. 20 at 8:38 PM
Bio-Rad Laboratories, Inc. Files SEC Form 8-K $BIO.B https://www.marketbeat.com/stocks/NYSE/BIO.B/sec-filings/
0 · Reply
EarningsInsider
EarningsInsider Jun. 15 at 9:21 PM
Bio-Rad Laboratories, Inc. Files SEC Form 144 $BIO.B https://www.marketbeat.com/stocks/NYSE/BIO.B/sec-filings/
0 · Reply
Latest News on BIO.B
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026

Jan 29, 2026, 8:30 AM EST - 6 days ago

Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026

Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio Activity

Jan 21, 2026, 1:33 PM EST - 14 days ago

Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio Activity

CABO CDW CNC EXPE FCNCA LKQ NOV

Longleaf Partners Global Fund 2025 Contributors And Detractors

Jan 15, 2026, 10:00 AM EST - 20 days ago

Longleaf Partners Global Fund 2025 Contributors And Detractors

ANGI AVTR IAC MGM TIGO

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference

Jan 6, 2026, 8:45 AM EST - 4 weeks ago

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference

Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 7:56 PM EDT - 3 months ago

Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call Transcript

Bio-Rad Reports Third-Quarter 2025 Financial Results

Oct 29, 2025, 4:15 PM EDT - 3 months ago

Bio-Rad Reports Third-Quarter 2025 Financial Results

Compelling Value In Small-Cap Equities And Select Cyclicals

Oct 23, 2025, 11:45 PM EDT - 3 months ago

Compelling Value In Small-Cap Equities And Select Cyclicals

AJG B CLB FISV HON MOS REZI

7 Stocks Taking The Next Step To Be On Offense

Oct 23, 2025, 7:30 PM EDT - 3 months ago

7 Stocks Taking The Next Step To Be On Offense

ACI CNX FCF FDX FIS IAC KHC

It's time to scoop up undervalued stocks in this critical sector of the economy

Oct 21, 2025, 11:07 AM EDT - 3 months ago

It's time to scoop up undervalued stocks in this critical sector of the economy

BSX ISRG SYK BDX BDYN FEGE JGLO

Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025

Oct 16, 2025, 5:30 PM EDT - 3 months ago

Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025

Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc.

Sep 4, 2025, 5:19 PM EDT - 5 months ago

Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc.

Bio-Rad Laboratories, Inc. (BIO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)

Sep 4, 2025, 5:07 PM EDT - 5 months ago

Bio-Rad Laboratories, Inc. (BIO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)

Bio-Rad's Management to Participate in Upcoming Investor Conferences

Aug 25, 2025, 9:00 AM EDT - 5 months ago

Bio-Rad's Management to Participate in Upcoming Investor Conferences

Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause

Aug 7, 2025, 7:30 AM EDT - 6 months ago

Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause

Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings

Aug 1, 2025, 11:30 AM EDT - 6 months ago

Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings

Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025

Aug 1, 2025, 9:00 AM EDT - 6 months ago

Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025

Bio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 9:55 PM EDT - 6 months ago

Bio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call Transcript

Bio-Rad Reports Second-Quarter 2025 Financial Results

Jul 31, 2025, 4:15 PM EDT - 6 months ago

Bio-Rad Reports Second-Quarter 2025 Financial Results

Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations

Jul 28, 2025, 4:15 PM EDT - 6 months ago

Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations

Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Jul 17, 2025, 4:15 PM EDT - 7 months ago

Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout

Jul 7, 2025, 9:00 AM EDT - 7 months ago

Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout

Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference

May 29, 2025, 4:30 PM EDT - 8 months ago

Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference

Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

May 12, 2025, 4:30 PM EDT - 9 months ago

Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript

May 1, 2025, 10:35 PM EDT - 9 months ago

Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript

Bio-Rad Reports First-Quarter 2025 Financial Results

May 1, 2025, 4:15 PM EDT - 9 months ago

Bio-Rad Reports First-Quarter 2025 Financial Results

Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 11:45 PM EST - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results

Feb 13, 2025, 4:20 PM EST - 1 year ago

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results

Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies

Feb 13, 2025, 4:15 PM EST - 1 year ago

Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies

Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025

Jan 27, 2025, 5:00 PM EST - 1 year ago

Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

Jan 8, 2025, 8:15 AM EST - 1 year ago

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

LH

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference

Jan 2, 2025, 4:30 PM EST - 1 year ago

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference

Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

Nov 21, 2024, 9:00 AM EST - 1 year ago

Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

Oct 31, 2024, 9:00 AM EDT - 1 year ago

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 8:22 PM EDT - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript

Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit

Oct 30, 2024, 6:09 PM EDT - 1 year ago

Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit

Bio-Rad Reports Third-Quarter 2024 Financial Results

Oct 30, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Third-Quarter 2024 Financial Results

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

Oct 14, 2024, 5:30 PM EDT - 1 year ago

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Sep 6, 2024, 6:43 PM EDT - 1 year ago

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

ADNT CHCT CMP CNH DBI DDD DELL

Bio-Rad's Management to Participate in Fireside Chat During Wells Fargo's 2024 Healthcare Conference

Aug 22, 2024, 4:30 PM EDT - 1 year ago

Bio-Rad's Management to Participate in Fireside Chat During Wells Fargo's 2024 Healthcare Conference

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

Aug 20, 2024, 8:30 AM EDT - 1 year ago

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

Bio-Rad Laboratories, Inc. (BIO) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 10:47 PM EDT - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q2 2024 Earnings Call Transcript

Bio-Rad Labs cuts annual revenue forecast on weak demand for diagnostics products

Aug 1, 2024, 5:56 PM EDT - 1 year ago

Bio-Rad Labs cuts annual revenue forecast on weak demand for diagnostics products

Bio-Rad Reports Second-Quarter 2024 Financial Results

Aug 1, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Second-Quarter 2024 Financial Results

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

Jul 17, 2024, 4:30 PM EDT - 1 year ago

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

May 30, 2024, 9:00 AM EDT - 1 year ago

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

May 23, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

Bio-Rad Laboratories, Inc. (BIO) Q1 2024 Earnings Call Transcript

May 7, 2024, 11:16 PM EDT - 1 year ago

Bio-Rad Laboratories, Inc. (BIO) Q1 2024 Earnings Call Transcript

Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip

May 7, 2024, 6:11 PM EDT - 1 year ago

Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip

Bio-Rad Reports First-Quarter 2024 Financial Results

May 7, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports First-Quarter 2024 Financial Results

Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

May 1, 2024, 9:00 AM EDT - 1 year ago

Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

MorenitaScorp
MorenitaScorp Sep. 11 at 1:28 AM
$BIO.B 🔬
0 · Reply
Bullish_Scanner
Bullish_Scanner Aug. 28 at 12:28 PM
Premarket Gappers $CWD $WAI $RAYA $TELO $BIO.B
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 31 at 7:05 PM
$BIO.B Excellent article that nails exactly where BIO-B stands right now. So if you want to update your BIO-B knowledge or get acquainted with BIO-B, this is a must read. https://beyondspx.com/article/bio-rad-laboratories-navigating-headwinds-with-strategic-investments-and-technological-edge-bio-b
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 9 at 11:14 AM
$BIO.B Excellent article that nails exactly where BIO-B stands right now. So if you want to update your BIO-B knowledge or get acquainted with BIO-B, this is a must read. https://beyondspx.com/article/bio-rad-laboratories-navigating-headwinds-with-strategic-investments-and-technological-edge-bio-b
0 · Reply
Robert1999
Robert1999 Aug. 2 at 4:24 PM
$BIO.B amazing today, Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Guidance Lowered🤩🤩. Hoping for positive news from $CBIO soon🥹🥹.
0 · Reply
Financhill
Financhill Dec. 6 at 8:00 AM
$BIO.B is rated a Sell since April 12, 2023 and is 42% below its median level.
0 · Reply
EarningsInsider
EarningsInsider Aug. 30 at 10:23 PM
Bio-Rad Laboratories, Inc. Files SEC Form 144 $BIO.B https://www.marketbeat.com/stocks/NYSE/BIO.B/sec-filings/
0 · Reply
EarningsInsider
EarningsInsider Aug. 4 at 8:54 PM
Bio-Rad Laboratories, Inc. Files SEC Form 10-Q $BIO.B https://www.marketbeat.com/stocks/NYSE/BIO.B/sec-filings/
0 · Reply
EarningsInsider
EarningsInsider Jul. 20 at 8:38 PM
Bio-Rad Laboratories, Inc. Files SEC Form 8-K $BIO.B https://www.marketbeat.com/stocks/NYSE/BIO.B/sec-filings/
0 · Reply
EarningsInsider
EarningsInsider Jun. 15 at 9:21 PM
Bio-Rad Laboratories, Inc. Files SEC Form 144 $BIO.B https://www.marketbeat.com/stocks/NYSE/BIO.B/sec-filings/
0 · Reply